SCHEMBL12629366

SCHEMBL12629366

O=NP(=O)(O)C(CCC(=O)O)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 7/20 0.64
GRM3 Q14832 3/20 0.46
NAALAD2 Q9Y3Q0 2/20 0.46
GRM8 O00222 2/20 0.42
GRM6 O15303 2/20 0.42
GRM7 Q14831 2/20 0.42
GRM4 Q14833 2/20 0.42
GGH Q92820 1/20 0.42
TET2 Q6N021 3/20 0.40
KDM4A O75164 2/20 0.40
KDM4C Q9H3R0 2/20 0.40
KDM2A Q9Y2K7 2/20 0.40
TET3 O43151 1/20 0.40
RIMKLA Q8IXN7 1/20 0.39
CYP1A2 P05177 2/20 0.39
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
GSR P00390 1/20 0.39
GRIK1 P39086 1/20 0.39
GRM5 P41594 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2201753 0.79 FOLH1 (1.00) FOLH1GRM3NAALAD2GRM8GRM6
Phosphonic Acid SCHEMBL15193462 0.72 FOLH1 (0.84) FOLH1GRM3NAALAD2GRM8GRM6
SCHEMBL9181835 0.68 FOLH1 (0.59) FOLH1GRM3NAALAD2GRM8GRM6
SCHEMBL10336815 0.67 FOLH1 (0.57) FOLH1GRM3NAALAD2GRM8GRM6
SCHEMBL9461890 0.67 FOLH1 (0.76) FOLH1GRM3NAALAD2
SCHEMBL11293793 0.67 FOLH1 (0.68) FOLH1GRM3NAALAD2
SCHEMBL11396532 0.65 FOLH1 (0.73) FOLH1GRM3NAALAD2
SCHEMBL8633245 0.64 FOLH1 (0.60) FOLH1GRM3NAALAD2GRM8GRM6
SCHEMBL1850194 0.64 FOLH1 (0.60) FOLH1GRM3NAALAD2GGHTET2
D-Glutamate SCHEMBL1065173 0.64 GRM8 (0.82) FOLH1GRM3GRM8GRM6GRM7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073286-A1 PROSTATE SPECIFIC MEMBRANE ANTIGEN INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-06-23 WO disclosed